#pharmaceutical-digital-marketing
#pharmaceutical-digital-marketing

[ follow ]

Business

Mizuho cuts Doximity stock price target on weaker growth outlook By Investing.com

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.

Business

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.

Mizuho cut Doximity’s price target to $26 and kept a Neutral rating due to weaker fiscal 2027 growth guidance and reduced industry marketing spend.

[ Load more ]